• Je něco špatně v tomto záznamu ?

Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review

P. Macinga, L. Bajer, M. Del Chiaro, ST. Chari, P. Dite, L. Frulloni, T. Ikeura, T. Kamisawa, K. Kubota, I. Naitoh, K. Okazaki, R. Pezzilli, M. Vujasinovic, J. Spicak, T. Hucl, M. Lӧhr

. 2021 ; 21 (5) : 928-937. [pub] 20210318

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012331

BACKGROUND: Chronic pancreatitis is a known risk factor of pancreatic cancer (PDAC). A similar association has been suggested but not demonstrated for autoimmune pancreatitis (AIP). OBJECTIVE: The aim of our study was to identify and analyse all published cases of AIP and PDAC co-occurrence, focusing on the interval between the diagnoses and the cancer site within the pancreas. METHODS: Relevant studies were identified through automatic searches of the MEDLINE, EMBASE, Scopus, and Web of Science databases, and supplemented by manual checks of reference lists in all retrieved articles. Missing/unpublished data were obtained from the authors of relevant publications in the form of pre-prepared questionnaires. RESULTS: A total of 45 cases of PDAC in AIP patients were identified, of which 12 were excluded from the analysis due to suspicions of duplicity or lack of sufficient data. Thirty-one patients (94%) had type 1 AIP. Synchronous occurrence of PDAC and AIP was reported in 11 patients (33%), metachronous in 22 patients (67%). In the metachronous group, the median period between diagnoses was 66.5 months (2-186) and a majority of cancers (86%) occurred more than two years after AIP diagnosis. In most patients (70%), the cancer originated in the part of the pancreas affected by AIP. CONCLUSIONS: In the literature, there are reports on numerous cases of PDAC in AIP patients. PDAC is more frequent in AIP type 1 patients, typically metachronous in character, and generally found in the part of the pancreas affected by AIP.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012331
003      
CZ-PrNML
005      
20220506130444.0
007      
ta
008      
220425s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.pan.2021.03.007 $2 doi
035    __
$a (PubMed)33775564
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Macinga, Peter $u Department of Gastroenterology and Hepatology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    10
$a Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review / $c P. Macinga, L. Bajer, M. Del Chiaro, ST. Chari, P. Dite, L. Frulloni, T. Ikeura, T. Kamisawa, K. Kubota, I. Naitoh, K. Okazaki, R. Pezzilli, M. Vujasinovic, J. Spicak, T. Hucl, M. Lӧhr
520    9_
$a BACKGROUND: Chronic pancreatitis is a known risk factor of pancreatic cancer (PDAC). A similar association has been suggested but not demonstrated for autoimmune pancreatitis (AIP). OBJECTIVE: The aim of our study was to identify and analyse all published cases of AIP and PDAC co-occurrence, focusing on the interval between the diagnoses and the cancer site within the pancreas. METHODS: Relevant studies were identified through automatic searches of the MEDLINE, EMBASE, Scopus, and Web of Science databases, and supplemented by manual checks of reference lists in all retrieved articles. Missing/unpublished data were obtained from the authors of relevant publications in the form of pre-prepared questionnaires. RESULTS: A total of 45 cases of PDAC in AIP patients were identified, of which 12 were excluded from the analysis due to suspicions of duplicity or lack of sufficient data. Thirty-one patients (94%) had type 1 AIP. Synchronous occurrence of PDAC and AIP was reported in 11 patients (33%), metachronous in 22 patients (67%). In the metachronous group, the median period between diagnoses was 66.5 months (2-186) and a majority of cancers (86%) occurred more than two years after AIP diagnosis. In most patients (70%), the cancer originated in the part of the pancreas affected by AIP. CONCLUSIONS: In the literature, there are reports on numerous cases of PDAC in AIP patients. PDAC is more frequent in AIP type 1 patients, typically metachronous in character, and generally found in the part of the pancreas affected by AIP.
650    12
$a autoimunitní nemoci $x komplikace $x diagnóza $x epidemiologie $7 D001327
650    12
$a autoimunitní pankreatitida $7 D000081012
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a lidé $7 D006801
650    12
$a nádory slinivky břišní $x komplikace $x diagnóza $x epidemiologie $7 D010190
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Bajer, Lukas $u Department of Gastroenterology and Hepatology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Del Chiaro, Marco $u Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA
700    1_
$a Chari, Suresh T $u Department of Gastroenterology, Hepatology and Nutrition, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA
700    1_
$a Dite, Petr $u Clinic of Internal Medicine, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Frulloni, Luca $u Gastroenterology Unit, Pancreas Center, University of Verona, Verona, Italy
700    1_
$a Ikeura, Tsukasa $u Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan
700    1_
$a Kamisawa, Terumi $u Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
700    1_
$a Kubota, Kensuke $u Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Japan
700    1_
$a Naitoh, Itaru $u Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
700    1_
$a Okazaki, Kazuichi $u Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan
700    1_
$a Pezzilli, Raffaele $u Department of Gastroenterology, San Carlo Hospital, Potenza, Italy
700    1_
$a Vujasinovic, Miroslav $u Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden; Department for Upper Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden
700    1_
$a Spicak, Julius $u Department of Gastroenterology and Hepatology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Hucl, Tomas $u Department of Gastroenterology and Hepatology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: tomas.hucl@ikem.cz
700    1_
$a Lӧhr, Matthias $u CLINTEC, Karolinska Institute, Stockholm, Sweden; Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden
773    0_
$w MED00008752 $t Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] $x 1424-3911 $g Roč. 21, č. 5 (2021), s. 928-937
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33775564 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130436 $b ABA008
999    __
$a ok $b bmc $g 1789777 $s 1163532
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 21 $c 5 $d 928-937 $e 20210318 $i 1424-3911 $m Pancreatology $n Pancreatology $x MED00008752
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace